[Back to Issue 12 ToC] [Back to Journal Contents] [Back to Biochemistry (Moscow) Home page]
[View Full Article] [Download Reprint (PDF)]

Bacterial Lipopolysaccharide Activates CD57-Negative Human NK Cells

L. M. Kanevskiy1, S. A. Erokhina1,2, M. A. Streltsova1, W. G. Telford3, A. M. Sapozhnikov1,2, and E. I. Kovalenko1*

1Shemyakin and Ovchinnikov Institute of Bioorganic Chemistry, Russian Academy of Sciences, ul. Miklukho-Maklaya 16/10, 117997 Moscow, Russia; E-mail: lenkovalen@mail.ru; leonid_kanewski@mail.ru

2Lomonosov Moscow State University, Faculty of Biology, 119991 Moscow, Russia

3Experimental Transplantation and Immunology Branch, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA

* To whom correspondence should be addressed.

Received July 27, 2014
NK cells play an important regulatory role in sepsis by induction and augmentation of proinflammatory reactions in early stages of the septic process and by suppression of immune response in later stages of inflammation. The present work was aimed at the effect of bacterial lipopolysaccharide (LPS), the main pathogenic factor of sepsis development, on human NK cells ex vivo. We show that LPS activates immature CD57-negative NK cells, which typically constitute less than half of the normal NK cell population in human peripheral blood. Under conditions of NK cell stimulation with IL-2, addition of LPS provokes an increase in IFN-γ production. However, LPS both increased and inhibited NK cell cytotoxic activity. It is important to note that the activation of NK cells on LPS addition was observed in the absence of TLR4 on the NK cell surface. These results confirm our previous data arguing for a direct interaction of LPS with NK cells and evidence an atypical mechanism of LPS-induced NK cell activation without the involvement of surface TLR4.
KEY WORDS: NK cells, lipopolysaccharide, IFN-γ production, CD57, cytotoxicity, TLR4

DOI: 10.1134/S0006297914120074